Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - Akari Therapeutics Plc | v434647_ex32.htm |
| EX-31.2 - EXHIBIT 31.2 - Akari Therapeutics Plc | v434647_ex31-2.htm |
| 10-K - 10-K - Akari Therapeutics Plc | v434647_10k.htm |
| EX-23.1 - EXHIBIT 23.1 - Akari Therapeutics Plc | v434647_ex23-1.htm |
| EX-31.1 - EXHIBIT 31.1 - Akari Therapeutics Plc | v434647_ex31-1.htm |
Exhibit 21.1
Company Subsidiaries
| 1. | Celsus Therapeutics Inc. (Incorporation date: 2 December 2002; Jurisdiction: Delaware) |
| 2. | Morria Biopharma Ltd. (Incorporation date: 22 March 2011; Jurisdiction: Israel) |
| 3. | Volution Immuno Pharmaceuticals SA (Incorporation date: 9 October 2013; Jurisdiction: Switzerland) |
| 4. | Volution Immuno Pharmaceutical (UK) Limited (Incorporation date: 22 August 2014; Jurisdiction: London) |